Showing results (151-160 of 181) with videos related to

Sort By:
Pageof 19
International Journal of Molecular Sciences|June 27, 2024
Programmed Death Ligand 1 (PD-L1) Expression in Lymphomas: State of the ArtMagda Zanelli, Valentina Fragliasso, Paola Parente, et al.
Pathology Oncology Research : POR|July 12, 2017
The Tumor Entity Denominated "clear cell-papillary renal cell carcinoma" According to the WHO 2016 new Classification, have the Clinical Characters of a Renal Cell Adenoma as does Harbor a Benign OutcomeFrancesco Massari, Chiara Ciccarese, Ondrej Hes, et al.
Cancers|July 20, 2021
Gastrointestinal Manifestations in Systemic Mastocytosis: The Need of a Multidisciplinary ApproachMagda Zanelli, Marco Pizzi, Francesca Sanguedolce, et al.
Frontiers in Oncology|January 29, 2024
Co-occurrence of JAK2-V617 F mutation and BCR::ABL1 translocation in chronic myeloproliferative neoplasms: a potentially confounding genetic combinationMagda Zanelli, Alessandra Bisagni, Francesca Sanguedolce, et al.
Cancer Biology & Therapy|June 29, 2011
Epigenetic fingerprint in endometrial carcinogenesis: the hypothesis of a uterine field cancerizationMarina Di Domenico, Angela Santoro, Carmela Ricciardi, et al.
Cancers|September 12, 2020
Acute Radiation Colitis after Preoperative Short-Course Radiotherapy for Rectal Cancer: A Morphological, Immunohistochemical and Genetic StudyMagda Zanelli, Alessia Ciarrocchi, Giovanni De Petris, et al.
European Urology Oncology|April 27, 2025
Impact of Immune Checkpoint Inhibitors as Neoadjuvant Therapy for Muscle-invasive Bladder Cancer: A Systematic Review, Meta-analysis, and Network Meta-analysisAkihiro Matsukawa, Angelo Cormio, Marcin Miszczyk, et al.
American Journal of Cancer Research|December 19, 2014
Methods to identify molecular expression of mTOR pathway: a rationale approach to stratify patients affected by clear cell renal cell carcinoma for more likely response to mTOR inhibitorsClaudia Fiorini, Francesco Massari, Serena Pedron, et al.
International Journal of Molecular Sciences|December 17, 2024
A Diagnostic Approach in Large B-Cell Lymphomas According to the Fifth World Health Organization and International Consensus Classifications and a Practical Algorithm in Routine PracticeMagda Zanelli, Francesca Sanguedolce, Maurizio Zizzo, et al.
Frontiers in Cell and Developmental Biology|April 10, 2024
Chronic myeloproliferative neoplasms with concomitant CALR mutation and BCR::ABL1 translocation: diagnostic and therapeutic implications of a rare hybrid diseaseMagda Zanelli, Valentina Fragliasso, Giuseppe Gaetano Loscocco, et al.
Pageof 19